Maimonides Cancer Center brings leading-edge treatments to our patients
The oncology experts at Maimonides stay on the leading edge of the latest discoveries and improvements in cancer care by participating in research studies and clinical trials designed to evaluate new approaches to cancer diagnoses and treatment.
Maimonides oncology research network’s capabilities include comprehensive clinical trials for cancer prevention, screening, diagnostics, treatment, supportive care/quality of life, and genetics.
Public reporting of outcomes in 2016
Maimonides compares our performance rates in the National Quality Forum (NQF) standards for care to the performance rates of other hospitals in New York State and the American College of Surgeons Eastern Division to ensure we are providing quality care.
Data as of 2016
The national standard for removal and examination of lymph nodes in colon cancer
Facts about cancer clinical trials
- More than 25,000 cancer patients enroll each year in clinical trials through the National Cancer Institute. Many more patients are enrolled in clinical trials sponsored by other groups
- About 60% of the adults enrolled in clinical trials are women
- Lung, breast, prostate, and colon cancers have the highest number of clinical trials — more than 40% of the total number of trials
- Only a small percentage of all cancer patients enroll in clinical trials. Their participation may benefit them as well as future cancer patients
For more information about clinical trials in your area or general information about cancer research, refer to: